clariscan 0.5 mmol/ml inj. sol. i.v. vial
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. vial
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. vial
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. vial
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. vial
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. vial
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. pre-filled syr.
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection in pre-filled syringe - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. pre-filled syr.
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection in pre-filled syringe - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. pre-filled syr.
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection in pre-filled syringe - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
dotagita 0,5 mmol/ml inj. sol. i.v. vial
agfa healthcare imaging agents gmbh - gadoterate meglumine 376,92 mg/ml - eq. gadoteric acid 279,32 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine 376.92 mg/ml - gadoteric acid